Megan Coylewright, MD, MPH, FACC, FSCAI

NEW ORLEANS — Treatment of severe tricuspid regurgitation with transcatheter repair was safe, reduced severity of tricuspid regurgitation and led to improvements in quality of life at 1 year, according to results of the TRILUMINATE Pivotal trial.

One celebrated advance to come from transcatheter aortic valve replacement is the evolution of a multidisciplinary heart team, utilizing skill sets of interventional cardiologists and cardiac surgeons to drive better outcomes for patients.